US 7,521,419 B2
Peptide-based compounds
Alan Cuthbertson, Oslo (Norway); Bard Indrevoll, Oslo (Norway); Magne Solbakken, Oslo (Norway); Torgrim Engell, Oslo (Norway); Colin Mill Archer, Amersham (United Kingdom); and Harry John Wadsworth, Amersham (United Kingdom)
Assigned to GE Healthcare AS, Oslo (Norway)
Filed on Jan. 08, 2004, as Appl. No. 10/753,729.
Application 10/753729 is a continuation of application No. PCT/NO02/00250, filed on Jul. 08, 2002.
Claims priority of application No. 0116815.2 (GB), filed on Jul. 10, 2001; and application No. 20014954 (NO), filed on Oct. 11, 2001.
Prior Publication US 2005/0070466 A1, Mar. 31, 2005
Int. Cl. A61K 38/00 (2006.01); A61K 38/12 (2006.01); C07K 5/00 (2006.01); C07K 7/00 (2006.01); C07K 16/00 (2006.01); C07K 17/00 (2006.01)
U.S. Cl. 514—10  [530/317] 6 Claims
 
1. A compound defined by the following formulas

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing

OG Complex Work Unit Drawing
or pharmaceutically acceptable salt thereof.